Dark

ABBV
ABBVIE INC.
stock NYSE

At Close

May 16, 2025 3:59:30 PM EDT

183.97USD+1.260%(+2.29)6,152,806

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 16, 2025 9:27:30 AM EDT

181.00USD-0.374%(-0.68)1,971

After-hours

May 16, 2025 4:55:30 PM EDT

182.54USD-0.777%(-1.43)65,750

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

324.97B

CEO

Richard Gonzalez

Headquarters

North Chicago, Illinois, USA

Industry

Drug Manufacturers-General

Next Earnings

Jul 23, 2025 (65d)

Last Dividend

Apr 15, 20251.640

AMGN NBIX GILD BIIB AZN GSK BMY LLY PFE XLV

ABBV Stats

Avg. Vol. 10 Day

8,766,500

Avg. Vol. 30 Day

9,321,369

Employees

30,000

Market Cap

324,972,937,051

Shares Out.

1,766,403,027

On/Off Exchange

55%/45%

6 Month Beta

0.45

1 Year Beta

0.37

2 Year Beta

0.35

3 Year Beta

0.35

52 Week Low

153.58

52 Week High

218.66

SMA50

193.73

SMA200

189.33

1 Week

-3.21%

1 Month

+6.35%

3 Month

-6.26%

6 Month

+10.64%

1 Year

+10.55%

2 Year

+28.26%

5 Year

+101.13%

Profile

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.

ABBV Stock Summary

ABBVIE INC. (NYSE:ABBV) stock price today is $183.97, and today's volume is 6,152,806. ABBV is up 1.260% today. The 30 day average volume is 9,321,369. ABBV market cap is 324.97B with 1,766,403,027 shares outstanding.

document.getElementById("jydWQl").onerror = function(){this.style.display='none';}; .dark-mode .Z08b3l{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .Z08b3l{ color: #333333; background-color: white; border: 2px solid #333333; }ABBVABBVIE INC.stock NYSE

ABBV Stock Summary

ABBV
ABBVIE INC.
stock NYSE